Soluble Human Leukocyte Antigen Molecules Detected in Orofacial Cleft Patients: A Case-Control Study

Authors

  • Regina Purnama Dewi Iskandar
  • Alida
  • Ari Triwardhani
  • Ida Bagus Narmada
  • Faizah Hanum
  • Arief Haryo Kusumo
  • Chairul Anwar Nidom
  • Sri Agus Sudjarwo

Keywords:

Cleft Palate, Cleft Lip, HLA Antigens

Abstract

Objective: To compare soluble HLA-C and HLA-DR molecules present in the plasma of orofacial cleft and non-orofacial cleft populations. Material and Methods: Orofacial cleft patients were recruited using an accidental sampling approach (n=15). Peripheral blood was collected from the participants and processed for Enzyme Linked Immunosorbent Assay (ELISA) against HLA-C and HLA-DR with specific antibodies. The absorbance was calculated utilizing ELISA reader. Data were statistically analyzed using an independent t-test to compare the disease and control groups. Results: The levels of soluble HLA-C and HLA-DR were significantly higher in the diseased group compared to the control group (p<0.05). Conclusion: The role of HLA molecules in non-communicable disease and congenital anomalies, particularly orofacial cleft, remains speculative despite the positive results of this study and  those  of previous investigations. It suggests that the variables examined may affect specific pathways involved in the pathogenesis of orofacial cleft, and predispose the individuals concerned to the oral cleft.

References

Pamplona MC, Ysunza PA. Language proficiency in children with cleft palate. Int Arch Commun Disord 2018; 1(1):003. https://doi.org/10.23937/iacod-2018/1810003

Mossey P, Little J. Addressing the challenges of cleft lip and palate research in India. Indian J Plast Surg 2009; 42(Suppl):S9–S18. https://doi.org/10.4103/0970-0358.57182

Burg ML, Chai Y, Yao CA, Magee W III, Figueiredo JC. Epidemiology, etiology, and treatment of isolated cleft palate. Front Physiol 2016; 7:67. https://doi.org/10.3389/fphys.2016.00067

Shkoukani MA, Chen M, Vong A. Cleft lip – a comprehensive review. Front Pediatr 2013; 1:53. https://doi.org/10.3389/fped.2013.00053

Goldberg AC, Rizzo LV. MHC structure and function – antigen presentation. Part 1. Einstein 2015; 13(1):153-6. https://doi.org/10.1590/S1679-45082015RB3122

Hosomichi K, Shiina T, Tajima A, Inoue I. The impact of next-generation sequencing technologies on HLA research. J Hum Genet 2015; 60(11):665-73. https://doi.org/10.1038/jhg.2015.102

Mosaad YM. Clinical role of human leukocyte antigen in health and disease. Scand J Immunol 2015; 82(4):283-306. https://doi.org/10.1111/sji.12329

Alves C, Vieira N, Meyer I, Alves CO, Toralles MBP, Oliveira MFSP. Human histocompatibility antigens and dermatology: from research to clinical practice. An Bras Dermatol 2006; 81(1):65-73. https://doi.org/10.1590/S0365-05962006000100009

Bodis G, Toth V, Schwartig A. Role of human leukocyte antigens (HLA) in autoimmune diseases. Rheumatol Ther 2018; 5(1):5-20. https://doi.org/10.1007/s40744-018-0100-z.

Insel R, Duta S, Hedrick J. Type 1 diabetes: disease stratification. Biomed Hub 2017; 2(Suppl. 1):481131. https://doi.org/10.1159/000481131

Dendrou CA, Petersen J, Rossjohn J, Fugger L. HLA variation and disease. Nat Rev Immunol 2018; 18(5):325-39 https://doi.org/10.1038/nri.2017.143

Akassou A, Bakri Y. Does HLA-B27 status influence ankylosing spondylitis phenotype?. Clin Med Insights Arthritis Musculoskelet Disord 2018; 11:1179544117751627. https://doi.org/10.1177/1179544117751627

Hollenbach JA, Norman PJ, Creary LE, Damotte V, Montero-Martin G, Caillier S, et al. A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson’s disease. PNAS 2019; 116(15):7419-24. https://doi.org/10.1073/pnas.1821778116

Valenzuela-Ponce H, Alva-Hernández, Garrido-Rodríguez D, Soto-Nava M, García-Téllez T, Escamilla Gómez T, et al. Novel HLA class I associations with HIV-1 control in a unique genetically admixed population. Sci Rep 2018; 8(1):6111. https://doi.org/10.1038/s41598-018-23849-7

Califf RM. Biomarker definitions and their applications: minireview. Experim Biol Med 2018.; 243(3):213-21. https://doi.org/10.1177/1535370217750088

Matzaraki V, Kumar V, Wijmenga C, Zhernakova A. The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol 2017; 18(1):76. https://doi.org/10.1186/s13059-017-1207-1

Nudel R, Simpson NH, Baird G, O’Hare A, Conti-Ramsden G, Bolton PF, et al. Association of HLA alleles with specific language impairment. J Neurodev Disord 2014; 6(1):1. https://doi.org/10.1186/1866-1955-6-1

Bennabi M, Gaman A, Delorme R, Boukouaci W, Manier C, Scheir I, et al. HLA-class II haplotypes and autism spectrum disorders. Sci Rep 2018; 8(1):7639. https://doi.org/10.1038/s41598-018-25974-9

Buhler S, Nunes JM, Sanchez-Mazas A. HLA Class I molecular variation and peptide-binding properties suggest a model of joint divergent asymmetric selection. Immunogenetics 2016; 68(6-7):401-16. https://doi.org/10.1007/s00251-016-0918-x

Wieczorek M, Abualrous ET, Sticht J, Álvaro-Benito M, Stolzenberg S, Noé F. Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation. Front Immunol 2017; 8:292. https://doi.org/10.3389/fimmu.2017.00292

Marazita ML. The evolution of human genetic studies of cleft lip and cleft palate. Annu Rev Genomics Hum Genet 2012; 13:263-83. https://doi.org/10.1146/annurev-genom-090711-163729

Bandoli G, Palmsten K, Smith CJF, Chambers CD. A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes. Rheum Dis Clin North Am 2017; 43(3):489-502. https://doi.org/10.1016/j.rdc.2017.04.013

Inoyatov A, Abdurahmanov M, Sharopov S, Azimov M. The condition of immune system of infants with congenital cleft lip and palate. Med Health Sci J 2012; 10:23-9. https://doi.org/10.15208/mhsj.2012.5

Rajendran R, Shaikh SF, Anil S. Tracing disease gene(s) in non-syndromic clefts of orofacial region: HLA haplotypic linkage by analyzing the microsatellite markers: MIB, C1_2_5, C1_4_1, and C1_2_A. Indian J Hum Gen 2011; 17(3):188-93. https://doi.org/10.4103/0971-6866.92101

Adeyemo WL, James O, Butali A. Cleft lip and palate: parental experiences of stigma, discrimination, and social/structural inequalities. Ann Maxillofac Surg 2016; 6(2):195-203. https://doi.org/10.4103/2231-0746.200336

Shirol SS. Sociocultural beliefs and perceptions about cleft lip-palate and their implications in the management, outcome, and rehabilitation. J Cleft Lip Palate Craniofac Anomal 2018; 5:4-5. https://doi.org/10.4103/jclpca.jclpca_41_17

Downloads

Published

2022-03-17

How to Cite

Iskandar, R. P. D. ., Alida, Triwardhani, A. ., Narmada, I. B. ., Hanum, F. ., Kusumo, A. H. ., Nidom, C. A., & Sudjarwo, S. A. . (2022). Soluble Human Leukocyte Antigen Molecules Detected in Orofacial Cleft Patients: A Case-Control Study. Pesquisa Brasileira Em Odontopediatria E Clínica Integrada, 20, e5096. Retrieved from https://revista.uepb.edu.br/PBOCI/article/view/1061

Issue

Section

Original Articles